• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在日本老年房颤登记研究的亚队列研究中,理解老年非瓣膜性房颤患者的情况和抗凝药物的依从性。

Comprehension of Nonvalvular Atrial Fibrillation and Anticoagulant Adherence in Elderly Patients in a Subcohort Study of the All Nippon Atrial Fibrillation in the Elderly Registry.

机构信息

Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

The Cardiovascular Institute, Tokyo, Japan.

出版信息

Am J Cardiol. 2023 Oct 1;204:159-167. doi: 10.1016/j.amjcard.2023.06.086. Epub 2023 Aug 4.

DOI:10.1016/j.amjcard.2023.06.086
PMID:37544138
Abstract

In this subcohort study of the ANAFIE (All Nippon Atrial Fibrillation In the Elderly) Registry enrolling >30,000 Japanese elderly (aged ≥75 years) patients with nonvalvular atrial fibrillation (NVAF), we assessed the association between patient comprehension of NVAF and adherence to anticoagulant therapy with clinical outcomes. Data from 1,968 patients evaluated for NVAF comprehension by a questionnaire consisting of 4 key questions, and 2,362 patients who completed the Morisky Medication Adherence Scale-8 questionnaire were analyzed. Overall, NVAF comprehension was low (81.9% had <3 points), and compared with high comprehension (score ≥3), low comprehension (0 points: 42.1%) was associated with poor prognosis, nonsignificantly higher risk of stroke or systemic embolic event (adjusted hazard ratio [aHR] 2.60 [95% confidence interval 0.97 to 6.94, p = 0.057]), all-cause death (aHR 1.71 [0.96 to 3.04, p = 0.069]), and significantly higher risk of net clinical outcome (composite of stroke/systemic embolic events, major bleeding, and all-cause death) (aHR 1.63 [1.04 to 2.54, p = 0.032]). Adherence to anticoagulant therapy assessed by Morisky Medication Adherence Scale-8 was high (64.9% had high adherence; 29.2%, had medium adherence), but compared with high adherence (score 8), low adherence (score <6: 5.9%) was associated with poor prognosis, significantly higher risk of ischemic stroke (aHR 2.95 [1.08 to 8.04, p = 0.035]), all-cause death (aHR 1.93 [1.16 to 3.21, p = 0.011]), and net clinical outcome (aHR 1.75 [1.12 to 2.75, p = 0.015]). Overall, NVAF comprehension and adherence showed a weak correlation to anticoagulant therapy at baseline (correlation coefficient 0.049). In conclusion, low NVAF comprehension and low anticoagulant adherence were associated with poor clinical outcomes in elderly patients with NVAF.

摘要

在这项纳入了 30000 多名日本老年(年龄≥75 岁)非瓣膜性心房颤动(NVAF)患者的 ANAFIE(日本所有老年心房颤动)登记处的亚组研究中,我们评估了患者对 NVAF 的理解程度与接受抗凝治疗的临床结果之间的关联。对 1968 名接受了包括 4 个关键问题的问卷评估 NVAF 理解程度的患者,以及 2362 名完成了 Morisky 药物依从性量表-8 问卷的患者进行了分析。总体而言,NVAF 理解程度较低(81.9%得分为<3 分),与高理解程度(得分≥3 分)相比,低理解程度(0 分:42.1%)与预后不良显著相关,非致命性卒中或全身性栓塞事件风险略高(校正后的危险比[aHR]2.60 [95%置信区间 0.97 至 6.94,p=0.057]),全因死亡风险(aHR 1.71 [0.96 至 3.04,p=0.069])和净临床结局(卒中/全身性栓塞事件、主要出血和全因死亡的复合结局)风险显著更高(aHR 1.63 [1.04 至 2.54,p=0.032])。采用 Morisky 药物依从性量表-8 评估的抗凝治疗依从性较高(64.9%为高依从性;29.2%为中依从性),但与高依从性(得分 8 分)相比,低依从性(得分<6 分:5.9%)与预后不良显著相关,非致命性缺血性卒中风险显著更高(aHR 2.95 [1.08 至 8.04,p=0.035]),全因死亡风险(aHR 1.93 [1.16 至 3.21,p=0.011])和净临床结局(aHR 1.75 [1.12 至 2.75,p=0.015])风险更高。总体而言,NVAF 理解程度和抗凝治疗依从性与基线时的抗凝治疗呈弱相关(相关系数 0.049)。总之,老年 NVAF 患者 NVAF 理解程度低和抗凝治疗依从性低与临床结局不良相关。

相似文献

1
Comprehension of Nonvalvular Atrial Fibrillation and Anticoagulant Adherence in Elderly Patients in a Subcohort Study of the All Nippon Atrial Fibrillation in the Elderly Registry.在日本老年房颤登记研究的亚队列研究中,理解老年非瓣膜性房颤患者的情况和抗凝药物的依从性。
Am J Cardiol. 2023 Oct 1;204:159-167. doi: 10.1016/j.amjcard.2023.06.086. Epub 2023 Aug 4.
2
Prognostic impact of heart rate during atrial fibrillation on clinical outcomes in elderly non-valvular atrial fibrillation patients: ANAFIE Registry sub-cohort study.老年非瓣膜性心房颤动患者心房颤动时心率对临床结局的预后影响:ANAFIE 登记研究亚组研究。
J Cardiol. 2023 May;81(5):441-449. doi: 10.1016/j.jjcc.2022.11.011. Epub 2022 Nov 22.
3
Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry.非瓣膜性心房颤动老年患者使用直接口服抗凝剂与华法林相比颅内出血和缺血性卒中的风险:ANA-FIE 登记研究分析。
Int J Stroke. 2023 Oct;18(8):986-995. doi: 10.1177/17474930231175807. Epub 2023 May 23.
4
Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: sub-analysis of ANAFIE Registry, a large observational study.糖化血红蛋白对老年房颤患者 2 年临床结局的影响:ANA-FIE 注册研究的亚组分析,一项大型观察性研究。
Cardiovasc Diabetol. 2023 Jul 12;22(1):175. doi: 10.1186/s12933-023-01915-3.
5
Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry.老年非瓣膜性心房颤动患者的前瞻性观察研究:全日空老年房颤(ANAFIE)注册研究的原理与设计
J Cardiol. 2018 Oct;72(4):300-306. doi: 10.1016/j.jjcc.2018.02.018. Epub 2018 Apr 3.
6
Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry.超过 30000 名老年房颤患者的两年结局:来自全日本老年房颤注册研究(ANAFIE)的结果。
Eur Heart J Qual Care Clin Outcomes. 2022 Mar 2;8(2):202-213. doi: 10.1093/ehjqcco/qcab025.
7
Background characteristics and anticoagulant usage patterns of elderly non-valvular atrial fibrillation patients in the ANAFIE registry: a prospective, multicentre, observational cohort study in Japan.ANAFIE 注册研究:日本一项前瞻性、多中心、观察性队列研究,评估老年非瓣膜性心房颤动患者的背景特征和抗凝治疗模式。
BMJ Open. 2021 Mar 8;11(3):e044501. doi: 10.1136/bmjopen-2020-044501.
8
Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry.质子泵抑制剂在日本老年非瓣膜性心房颤动患者中的使用现状:ANA-FIE 登记研究的亚分析。
PLoS One. 2020 Nov 5;15(11):e0240859. doi: 10.1371/journal.pone.0240859. eCollection 2020.
9
Effect of Cancer on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation - Substudy of the ANAFIE Registry.癌症对老年非瓣膜性心房颤动患者临床结局的影响——ANA-FIE 注册研究的亚研究。
Circ J. 2022 Jan 25;86(2):202-210. doi: 10.1253/circj.CJ-21-0631. Epub 2021 Nov 30.
10
Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new-onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study.新型急性缺血性脑卒中伴非瓣膜性心房颤动患者使用口服抗凝剂及其相关因素:来自中国心房颤动登记研究的报告。
Clin Cardiol. 2022 Jan;45(1):60-67. doi: 10.1002/clc.23759. Epub 2021 Dec 24.

引用本文的文献

1
Patient-centered integration of the treatment and prevention of cardiovascular diseases in the community: a digital intelligence exploration.以患者为中心的社区心血管疾病治疗与预防整合:数字智能探索
Front Med (Lausanne). 2025 Jul 8;12:1593238. doi: 10.3389/fmed.2025.1593238. eCollection 2025.
2
Association Between Oral Anticoagulant Adherence and Serious Clinical Outcomes in Patients With Atrial Fibrillation: A Long-Term Retrospective Cohort Study.口服抗凝药物治疗依从性与房颤患者严重临床结局的相关性:一项长期回顾性队列研究。
J Am Heart Assoc. 2024 Sep 17;13(18):e035639. doi: 10.1161/JAHA.124.035639. Epub 2024 Sep 9.